CCL22

CCL22

CCL22 Informations sur la molécule

Molecule Name
ATP Binding Cassette Subfamily D Member 1
Alias de la molécule
MDC,ABCD-1,SCYA22,STCP-1,DC,B-CK,A-152E5.1
Drug Development Progress
Nombre de médicaments cliniques2
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
ATP Binding Cassette Subfamily D Member 1,Adrenoleukodystrophy Protein,ATP-Binding Cassette Sub-Family D Member 1,ALDP,ATP-Binding Cassette, Sub-Family D (ALD), Member 1,ABC42,ABCD1,AMN,ALD,ATP Binding Cassette Transporter, Subfamily D, Member 1,Adrenoleukodystrophy
Contexte de la molécule
This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, dendritic cells, natural killer cells and for chronically activated T lymphocytes. It also displays a mild activity for primary activated T lymphocytes and has no chemoattractant activity for neutrophils, eosinophils and resting T lymphocytes. The product of this gene binds to chemokine receptor CCR4. This chemokine may play a role in the trafficking of activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology.

CCL22 Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Pozetaldogene ormesparvovecSBT-101Phase 2 ClinicalSwanBio Therapeutics Ltd
Adrenoleukodystrophy
Details
TYF-ABCD1TYF-ABCD1ClinicalShenzhen Geno-Immune Medical Institute
Adrenoleukodystrophy
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Elivaldogene autotemcelApprovedGenetix Biotherapeutics Inc, InsermLenti-D, SkysonaUnited StatesAdrenoleukodystrophyGenetix Biotherapeutics Inc2021-07-27
Adrenoleukodystrophy
Details